title: Thalidomide-Related Eosinophilic Pneumonia: A case report and brief literature review.
abstract: Thalidomide has regained value in the multimodality treatment of leprosy, multiple myeloma, prostate, ovarian and renal cancer. Complications related to arterial and venous complications are well described. However, pulmonary complications remain relatively uncommon. The most common pulmonary side-effect reported is non-specific dyspnea. We report a patient with multiple myeloma, who developed an eosinophilic pneumonia, shortly after starting thalidomide. She had complete resolution of her symptoms and pulmonary infiltrates on discontinuation of the drug and treatment with corticosteroids. Physicians should be cognizant of this potential complication in patients receiving thalidomide who present with dyspnea and pulmonary infiltrates.
authors.affiliation: Respiratory Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio, 44195, USA. tillucl@ccf.org.
authors.forename: Lisa
authors.initials: L
authors.lastname: Tilluckdharry
authors.forename: Robert
authors.initials: R
authors.lastname: Dean
authors.forename: Carol
authors.initials: C
authors.lastname: Farver
authors.forename: Muzaffar
authors.initials: M
authors.lastname: Ahmad
references.citation: Ann Pharmacother. 2005 May;39(5):962-5
references.pmid: 15811905
references.citation: Arch Bronconeumol. 2002 Oct;38(10):492-4
references.pmid: 12372201
references.citation: N Engl J Med. 1999 Nov 18;341(21):1606-9
references.pmid: 10564693
references.citation: Br J Haematol. 2003 Apr;121(1):191-2
references.pmid: 12670354
references.citation: J Clin Oncol. 2004 Jun 15;22(12):2477-88
references.pmid: 15197211
references.citation: South Med J. 2006 Nov;99(11):1292-4
references.pmid: 17195429
references.citation: Chest. 2007 May;131(5):1572-4
references.pmid: 17494808
references.citation: J Clin Oncol. 2002 Nov 1;20(21):4319-23
references.pmid: 12409330
references.citation: Gynecol Oncol. 2008 Dec;111(3):546-8
references.pmid: 18191185
references.citation: Br J Haematol. 2005 Mar;128(6):885-7; author reply 887-8
references.pmid: 15755296
references.citation: Rinsho Ketsueki. 2004 Sep;45(9):1064-6
references.pmid: 15510838
references.citation: Am J Ther. 2003 May-Jun;10(3):228-32
references.pmid: 12756431
references.citation: Blood. 2002 Jun 1;99(11):4247-8
references.pmid: 12043695
references.citation: Blood. 2001 Sep 1;98(5):1614-5
references.pmid: 11520815
references.citation: Ann Oncol. 2004 Jan;15(1):134-8
references.pmid: 14679133
references.citation: J Clin Oncol. 2005 Apr 1;23(10):2425-6
references.pmid: 15800335
references.citation: Arch Med Res. 2008 Feb;39(2):257-8
references.pmid: 18164975
references.citation: Thromb Haemost. 2004 Apr;91(4):834-6
references.pmid: 15045155